Cogenics

Cogenics provides a full range of genomic services for both research and regulated projects, including services to support pharmacogenomics discovery and validation in addition to biomarker research and development. We offer integrated services for DNA and RNA extraction, genotyping, a full range of traditional and next generation sequencing and gene expression. Additional services are offered to support multiple applications of QPCR, cell bank characterization and biorepository/biobanking. Cogenics combines operations from Genaissance, Lark, Icoria, Genome Express, and Epidauros - leveraging over 18 years of genomics experience to deliver superior quality in genomics services. We currently employ around 200 people and operate facilities in Texas, North Carolina, the UK, France, and Germany.